Clinical Research Needs To Move ‘Out Of The Ivory Tower,’ FDA’s Woodcock Urges

 
• By Brenda Sandburg

Acting Commissioner says she is ‘really going to be pushing’ to have clinical trials conducted in the community. CDER’s Cavazzoni and CBER’s Marks discuss master protocols, decentralized trials, and real world evidence at DIA’s annual meeting.

Sign outside of FDA's headquarters in White Oak, MD
FDA officials advocate moving clinical trials into communities

More from Clinical Trials

More from R&D